Population Genetics Technologies Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Population Genetics Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10322
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Population Genetics Technologies Ltd (Population Genetics), a subsidiary of Agilent Technologies Inc is a biotechnology company. The company commercialize nucleic acid biochemistry tools and approaches. Its intellectual property assets include method for normalizing a nucleic acid sample, method for fragmenting a nucleic acid for sequencing, method for identifying minority variants in a sample, methods and compositions for isolating nucleic acid sequence variants, multiplexed analytical platform and others. The company currently markets certain intellectual property families within its portfolio, targeting companies in the molecular diagnostic and broader sequencing and life science tools sectors. Population Genetics is headquartered in Cambridge, the UK.

Population Genetics Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Population Genetics Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Population Genetics Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Population Genetics Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Population Genetics Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Population Genetics Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Population Genetics Technologies Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Population Genetics Enters into Agreement with Case Western Reserve University to Develop Diagnostics Technology 10
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 11
Asset Transactions 12
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 12
Population Genetics Technologies Ltd – Key Competitors 13
Population Genetics Technologies Ltd – Key Employees 14
Population Genetics Technologies Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Population Genetics Technologies Ltd, Medical Equipment, Key Facts 2
Population Genetics Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Population Genetics Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Population Genetics Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Population Genetics Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Population Genetics Technologies Ltd, Deals By Market, 2012 to YTD 2018 8
Population Genetics Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Population Genetics Enters into Agreement with Case Western Reserve University to Develop Diagnostics Technology 10
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 11
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 12
Population Genetics Technologies Ltd, Key Competitors 13
Population Genetics Technologies Ltd, Key Employees 14

List of Figures
Population Genetics Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Population Genetics Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Population Genetics Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Population Genetics Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Population Genetics Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Population Genetics Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Population Genetics Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Population Genetics Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Population Genetics Technologies Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endocyte Inc (ECYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • Comet Ridge Ltd (COI):石油・ガス:M&Aディール及び事業提携情報
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • National Grid USA Service Co Inc:企業の戦略的SWOT分析
    National Grid USA Service Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • RCM Technologies Inc (RCMT):企業の財務・戦略的SWOT分析
    RCM Technologies Inc (RCMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • UDG Healthcare Plc (UDG):企業の財務・戦略的SWOT分析
    UDG Healthcare Plc (UDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • Matica Technologies AG:企業の戦略的SWOT分析
    Matica Technologies AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Opiant Pharmaceuticals Inc (OPNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Schneider Electric SE:企業の戦略・SWOT・財務分析
    Schneider Electric SE - Strategy, SWOT and Corporate Finance Report Summary Schneider Electric SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ascend Therapeutics US LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascend Therapeutics US LLC (Ascend Therapeutics), a subsidiary of Besins Healthcare SA, is a pharmaceutical company that offers women’s healthcare products. The company discovers, develops and markets transdermal drug delivery products. Its product includes estrogel, a non patch transdermal …
  • Monogram Biosciences Inc:企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Tamir Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tamir Biotechnology Inc (Tamir Biotechnology), formerly Alfacell Corp is a clinical stage antiviral therapeutics company that discovers and develops prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions. The company’s targets include human papillom …
  • Tata Consultancy Services Limited:企業の戦略・SWOT・財務分析
    Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Autobio Diagnostics Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Autobio Diagnostics Co Ltd (Autobio) is a clinical diagnostic company that offers research and development; production and distribution of clinical diagnostic products. The company’s products include immunoassays, mycoplasma, blood culture bottle, bacterial vaginosis, microplate luminometer, …
  • InterOil Exploration & Production ASA (IOX):企業の財務・戦略的SWOT分析
    Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, develops and operates oil and natural gas properties, among others. It operates as an active license partner in se …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aramark (ARMK):企業の財務・戦略的SWOT分析
    Aramark (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆